
Zenas BioPharma Investors Encouraged to Contact Cohen Milstein to Lead ZBIO IPO Stock Drop Securities Class Action
WASHINGTON, April 25, 2025 (GLOBE NEWSWIRE) -- Retail investors who purchased shares of Zenas BioPharma, Inc. (NASDAQ: ZBIO) in the company’s September 2024 initial public offering may have the chance to lead a securities class action lawsuit now pending …